Skip to content

Drug interactions

Elvitegravir / cobicistat / emtricitabine / tenofovir df + Paroxetine

Severity: Moderate

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Paroxetine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobicistat inhibits CYP2D6, the main pathway for paroxetine clearance, so paroxetine concentrations may rise. This can increase adverse effects such as nausea, sedation, anticholinergic effects and serotonergic toxicity.

What this interaction means in plain words

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Paroxetine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Cobicistat inhibits CYP2D6-mediated metabolism of paroxetine.

What to do

Start paroxetine at a low dose and titrate to clinical response. Monitor for adverse effects and reduce the dose if they develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir / cobicistat / emtricitabine / tenofovir df and Paroxetine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Paroxetine?

MediHelp rates the interaction as moderate. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Paroxetine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cobicistat inhibits CYP2D6, the main pathway for paroxetine clearance, so paroxetine concentrations may rise. This can increase adverse effects such as nausea, sedation, anticholinergic effects and serotonergic toxicity.

How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Paroxetine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Start paroxetine at a low dose and titrate to clinical response. Monitor for adverse effects and reduce the dose if they develop.

What other medicines interact with Paroxetine?

MediHelp also lists interactions of Paroxetine with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Paroxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in